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a healthy individual in Raiatea Island (French Polynesia, South Paciﬁc). Actinomyces massiliensis is an anaerobic, Gram-positive organism. Here
we describe the features of this organism, together with the complete genome sequence and annotation—2 943 271 bp with a 70.80% G+C
content, assembled into 15 scaffolds and containing 2080 genes.
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E-mail: jean-marc.rolain@univ-amu.frIntroductionThe genus Actinomyces belongs to the domain Bacteria, Phylum
Actinobacteria, Class Actinobacteria, Order Actinomycetales and
Family Actinomycetaceae. The genus consists of a heteroge-
neous group of Gram-positive bacteria that have a high G+C
content [1].
The genus Actinomyces consists of a heterogeneous group of
Gram-positive bacilli, mainly facultatively anaerobic or micro-
aerophilic rods with various degrees of branching [2]. Actino-
myces species mainly belong to the human commensal ﬂora of
the oropharynx, gastrointestinal tract, and urogenital tract [3].
Actinomycosis is a very rare disease usually caused by one of
a group of opportunistic but otherwise harmless commensals
and may be complicated by one or more of another group of
co-pathogens [4]. Actinomycetes are prominent among the© 2016 The Authors. Published by El
This is an open access artinormal ﬂora of the oral cavity but less prominent in the lower
gastrointestinal tract and female genital tract. As these micro-
organisms are not virulent, they require a break in the integrity
of the mucous membranes and the presence of devitalized
tissue to invade deeper body structures and cause human illness
[4]. Many studies based on phenotypic identiﬁcation of mem-
bers of the genus Actinomyces have been performed. Several
ﬂowcharts have been proposed to enable accurate differentia-
tion. However, during the past few years, Actinomyces taxon-
omy has undergone much improvement, primarily driven by
16S rRNA gene sequence analysis [5]. The study of Actinomyces
polynesiensis str. MS2 is part of a project called ‘Culturomics’,
the comprehensive determination of the microbial composition
of the gut microbiota and the relationships with health and
disease, which are major challenges in the twenty-ﬁrst century.
Metagenomic analysis of the human gut microbiota detects
mostly uncultured bacteria as reported here [6].Materials and MethodsGrowth conditions and identiﬁcation
Actinomyces polynesiensis sp. nov., strain MS2 (=CSURP658=
DSMZ 27066).New Microbe and New Infect 2016; 12: 1–5
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stools of a healthy individual in Raiatea Island (French Polynesia,
South Paciﬁc). Actinomyces polynesiensis MS2 was isolated for the
ﬁrst time using inoculation in a blood culture bottle with co-
conut milk and then 5% sheep blood agar. Growth was tested
on Columbia agar supplemented with 5% sheep blood and
chocolate agar + PolyViteX (bioMérieux, Marcy-l’Étoile,
France) in aerobic and anaerobic condition using GasPak™ EZ
Anaerobe Container System Sachets (BD, Franklin Lakes, NJ,
USA) at 37°C and CO2 Gen (ThermoScientiﬁc, Waltham, MA,
USA). The ability of the strain to grow at different temperatures
(25°C, 37°C and 45°C) was investigated.
Gram staining and electron microscopy were performed
with a TechnaiG2 Cryo (FEI Company, Hillsboro, OR, USA) at
an operating voltage of 200 keV. Cells were grown on 5%
sheep-blood agar for 24 h. A bacterial suspension was pre-ﬁxed
in 5% (volume/volume) glutaraldehyde in phosphate buffer
(Gibco, Waltham, MA, USA) for at least 1 h at room temper-
ature, washed in the same buffer and stained with 1% (weight/
volume) ammonium molybdate 1%. Catalase activity, as deter-
mined by an ID Color catalase test kit (bioMérieux) and oxidase
activity, assayed by applying the cells to moistened discs
impregnated with dimethyl-p-phenylenediamine (bioMérieux).
Biochemical tests were performed with the commercially
available API ZYM and API 50 CH strips and were used to
characterize the biochemical properties of the strain according
to the manufacturer’s instructions. The bacterium was identi-
ﬁed by sequence analysis of the 16S rRNA. Phylogenetic rela-
tionship with closely related species were determined using
MEGA version 5.1. The evolutionary history was inferred using
the maximum likelihood method based on the JTT matrix-based
model [7].
Antibiotic susceptibility testing
Antibiotic susceptibility testing was conducted using the disc
diffusion method on Müller–Hinton agar supplemented with 5%
sheep blood medium (bioMérieux) and the results were
interpreted using the European Committee on Antimicrobial
Susceptibility Testing (EUCAST) guidelines [8]. The antibiotics
used in this study were penicillin, oxacillin, vancomycin, teico-
planin, linezolid, gentamicin, ciproﬂoxacin, trimethroprim-
sulphamethoxazole, fosfomycin, doxycycline, erythromycin,
clindamycin, rifampicin and colistin.
Genome sequencing
DNA extracted through the BioRobot EZ 1 Advanced XL
(Qiagen, Hilden, Germany) paired end library was pyrose-
quenced on the 454_Roche_Titanium. The global 297 979
passed ﬁlter sequences generated 85.84 Mb with a length
average of 281 bp. These sequences were assembled on the© 2016 The Authors. Published by Elsevier Ltd on behalf of European Society of Clinical Microb
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licegsAssembler from Roche with 90% identity and 40 bp as
overlap (Roche, Basel, Switzerland). It leads to 15 scaffolds and
309 large contigs (>1500 bp), generating a genome size of 2.94
Mb, which corresponds to a coverage of 29.2 genome
equivalent.
Genome annotation
The genome was annotated by Rapid Annotation using the
Subsytem Technology (RAST) bioserver [9]. BLAST2GO opti-
mizes the function transfer from homologous sequences
through an elaborate algorithm that considers the similarity, the
extension of the homology, the database of choice, the GO
hierarchy, and the quality of the original annotations [10]. The
resistome was analysed with the ARG-ANNOT (Antibiotic
Resistance Gene-ANNOTation) database [11] and BLASTp in
GenBank. The prediction of rRNAs was carried out using the
RNAmmer tools [12]. The exhaustive bacteriocin database
available in our laboratories (Bacteriocins of the URMITE
database; http://drissifatima.wix.com/bacteriocins) was per-
formed by collecting all currently available sequences from the
databases and from NCBI. Protein sequences from this data-
base allowed putative bacteriocins from human gut microbiota
to be identiﬁed using BLASTp methodology [13].ResultsDescription of Actinomyces polynesiensis sp. nov., strain
MS2
Phenotypic properties. Actinomyces polynesiensis (polinesiense masc.
adj. of πoλυνησίας, the ancient Greek name for the islands of
French Polynesia, where the strain was isolated). Actinomyces
polynesiensis grew slowly, with characteristics similar to those of
the ﬁlamentous fungi; which have the ability to grow in
branched ﬁlaments and to form settlers and the typical myce-
lium seen with other smaller beaded white colonies (Fig. 1).
Actinomyces polynesiensis MS2 was grown anaerobically on 5%
sheep-blood-enriched Columbia agar at 37°C. Optimal growth
was achieved anaerobically using chocolate agar + PolyViteX
with 5% CO2 at 37°C and no growth was observed under
aerobic conditions. Catalase and oxidase activity were respec-
tively positive and negative. A motility test was positive. Acid
production was observed for the following carbohydrates, with
API 50 CH negative for D-arabinose, L-xylose, D-adonitol,
methyl-β-D-xylopyranoside, L-sorbose, L-rhamnose, dulcitol,
inuline, D-tagatose, D-fucose, L-arabitol, potassium 2- and 5-
gluconate; all other acid production was positive (Table 1). All
activities were negative with API ZYM (Table 1).
Further identiﬁcation was performed using a 16S rRNA
nucleotide sequence (GenBank accession number HF952919)iology and Infectious Diseases, NMNI, 12, 1–5
nses/by-nc-nd/4.0/).
FIG. 1. (a) Actinomyces polynesiensis str.
MS2 isolated on Müller–Hinton agar sup-
plemented with 5% sheep blood medium
(bioMérieux); (b) Gram staining of Actino-
myces polynesiensis str. MS2; (c) electron
microscopy of Actinomyces polynesiensis str.
MS2 performed with a TechnaiG2 Cryo
(FEI Company) at an operating voltage of
200 keV.
TABLE 1. Acid production compared between four
Actinomyces species
Test 1 2 3 4
Acid production
Glycerol + – nd nd
L-Arabinose + – + +
D-Ribose + – nd nd
D-Xylose + – nd nd
D-Galactose + + nd nd
D-Glucose + + + +
D-Fructose + + nd nd
D-Mannose + – nd –
Inositol + – nd nd
D-Mannitol + – – +
Methyl β-D-glucopyranoside + – – –
N-Acetylglucosamine + – nd nd
Amygdalin + – nd nd
Aesculin + – + +
Salicin + – nd nd
Cellobiose + – nd nd
Lactose + + – +
Melibiose + – + –
Rafﬁnose + – + –
Gentiobose + – nd nd
Turanose + – nd nd
D-Lyxose + – nd nd
APi ZYM
Esterase – – – –
Valine arylamidase – + – –
α-Galactosidase – – + –
β-Galactosidase – + + +
α-Glucosidase – + – +
β-Glucosidase – – + +
1, Actinomyces polynesiensis str. MS2; 2, Actinomyces israelii CIP 103259;
3, Actinomyces suimastitidis DSM15538; 4, Actinomyces vaccimaxillae DSM 15804
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accession number DQ278863.1) (Fig. 2). This value was lower
than the 95% 16S rRNA gene sequence threshold recom-
mended by Stackebrandt and Elbers to delineate a new genus
without carrying out DNA-DNA hybridization [14]. The
spectrum from MS2 was added to our MALDI-TOF mass
spectra database.
Phenotypically, A. polynesiensis str. MS2 was resistant to
oxacillin, second-generation (cefoxitine) and third-generation
cephalosporins (ceftriaxone), trimethroprim-
sulphamethoxazole, fosfomicin, erythromycin and clindamycin
but was susceptible to vancomycin, teicoplanin, linezolid,
gentamicin, ciproﬂoxacin, doxycycline, rifampicin and colistin
(Fig. 2).
Genome features. The genome size of Actinomyces polynesiensis
str. MS2 is 2 943 271 bp with a 70.80% G+C content assembled
into 15 scaffolds (309 contig). A total of 2080 genes (91%) were
assigned to putative functions (by clusters of orthologous
groups) and 216 (9%) genes were identiﬁed as unknown func-
tion and 110 were RNAs, ten genes were 5S rRNA, nine genes
were 16S rRNA and four genes were 23S rRNA. The distri-
bution of genes into clusters of orthologous group functional
categories is presented in Table 2 and the properties and sta-
tistics of the genome are summarized in Table 3.alf of European Society of Clinical Microbiology and Infectious Diseases, NMNI, 12, 1–5
le under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
FIG. 2. Molecular phylogenetic analysis by maximum likelihood method of representatives of genus Actinomyces inferred from 16SrRNA gene
sequence.
4 New Microbes and New Infections, Volume 12 Number C, July 2016 NMNIResistome. The resistome of this multidrug-resistant Actinomyces
polynesiensis str. MS2 includes penicillin-binding protein (296
amino acids), metallo-hydrolase enzyme (239 amino acids) and
the major facilitator superfamily (Table 4).TABLE 2. Number of genes associated with 25 general
functional categories of clusters of orthologous groups
(COGs)
COG class Calue Description
A 32 RNA processing and modiﬁcation
C 126 Energy production and conversion
D 30 Cell cycle control, cell division, chromosome partitioning
E 204 Amino acid transport and metabolism
F 80 Nucleotide transport and metabolism
G 239 Carbohydrate transport and metabolism
H 70 Coenzyme transport and metabolism
I 61 Lipid transport and metabolism
J 156 Translation, ribosomal structure and biogenesis
K 183 Transcription
L 135 Replication, recombination and repair
M 120 Cell wall/membrane/envelope biogenesis
N 2 Cell motility
O 68 Post-translational modiﬁcation, protein turnover, chaperones
P 132 Inorganic ion transport and metabolism
Q 24 Secondary metabolites biosynthesis, transport and catabolism
R 245 General function prediction only
S 216 Function unknown
T 87 Signal transduction mechanisms
U 37 Intracellular trafﬁcking, secretion, and vesicular transport
V 49 Defence mechanisms
© 2016 The Authors. Published by Elsevier Ltd on behalf of European Society of Clinical Microb
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that is neutralized by a metabolically unstable antitoxin [15].
The analysis of the genome has not demonstrated the
presence of bacteriocin and non-ribosomal polyketide
synthase.ConclusionOn the basis of the phylogenetic analysis, the novel species
Actinomyces polynesiensis str. MS2 sp. nov. is proposed with the
accession number CCXH01000000 in the GenBank database.TABLE 3. Genome properties of Actinomyces polynesiensis str.
MS2
Size Mb GC% Genes Protein
Actinomyces polynesiensis str. MS2 2.87 70.80 2514 2566
Actinomyces israelii CIP 103259 4.03 71 3262 3125
Actinomyces odontolyticus ATCC 17982 2.39 65.4 2054 1982
Actinomyces georgiaeDSM 6843 2.5 69.80 2102 2031
Actinomyces suimastitidis DSM15538 2.29 56.4 1960 1891
Actinomyces vaccimaxillae DSM 15804 2.34 57.6 2067 1991
iology and Infectious Diseases, NMNI, 12, 1–5
nses/by-nc-nd/4.0/).
TABLE 4. List of genes associated with antibiotic resistant in Actinomyces polynesiensis str. MS2
Open reading frame Gene name GC% Size aa Function Best blast hit in GenBank % aa coverage % aa identity
WP_043535219.1 MBL 74.4 239 metallo-hydrolase Actinomyces SD1 100 65
WP052450410.1 MFS 71.3 510 MFS transporter Leifsonia aquatica 96 58
WP_043535826.1 PBP 73 269 penicillin-binding protein Actinomyces vaccimaxillae 99 58
aa, amino acids; MBL, metallo-hydrolase enzyme; MFS, the major facilitator superfamily; PBP, penicillin-binding protein.
NMNI Cimmino et al. Actinomyces polynesiensis str. MS2 sp. nov. 5Genome Sequence Accession NumberThe genome of Actinomyces polynesiensis str. MS2 has been
submitted to the EBI database under bioproject ID: PRJEB1958
with accession number on GenBank database CCXH01000000
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